CMS just announced a $3m gift for longevity and functional medicine
Hot off the press! The Centers for Medicare and Medicaid just announced a new model - called Elevate - as part of the Make America Healthy Again (“MAHA”) agenda.
What we know so far:
- CMS will make available $100 million of total funding for up to 30 disease prevention and health promotion pilot projects.
- These projects must not already be covered by Original Medicare.
- The programs must be evidence-based and cover “whole person” care and then assess the data related to cost, quality, impact and scalability for older populations.
- Each pilot will get up to $3 million over three years.
- All proposals must incorporate nutrition assistance or physical activity as part of the design.
- Cooperative agreement funds can be used to support hiring dieticians and nutritionists or for nutrition counseling and classes, but not for purchasing food.
Bottom line: Countless companies in digital health could potentially quality, inclusive of all the players in the nutrition category, those in functional medicine and also in longevity. It’s a gift for an industry that has struggled to find reimbursement sources for prevention, particularly in Medicare where the impact can be massive if an intervention can reach a senior in the mid-sixties and seventies before they become vulnerable and chronically ill.
What we don’t know: How CMS will define “whole person” care, as well as the requirements around how this data will be tracked are an open question. What is clear is that it must be used for services that Original Medicare does not cover, and must be backed by evidence.
What else: This is particularly important for venture-backed early-stage companies that need every penny they can get to extend their runway. $1 million a year is significant. And there could be potential for more funds, assuming the pilots go well.
Keep an eye out for CMS to issue a Notice of Funding Opportunity in February. Companies can submit multiple applications, according to the FAQ released by CMS. CMS has said that companies that submit applications must include scientific evidence to prove that these programs do, in fact, work. Follow along for more policy updates.
A smart take: “Because Medicare is a statutory benefit program that only advances as Congress moves the needle incrementally forward, the way the program approaches “whole person health” is really decades behind. Services like health coaching, health education, and nutrition support are evidence-based approaches to lowering the cost of care, but pathways to cover and pay for these services through Medicare are clunky and limited (think limited chronic care management codes),” said Manatt’s Ross Margulies. We know already that these evidence-based lifestyle approaches work – and dozens and dozens of innovative (and often tech-enabled) companies are already delivering these services. These pilots will offer the opportunity to really cement this evidence-based and the limited nature of the model suggests to me that CMS would be open to future expansion, including permanent coverage of some of these services.”
More information is available as of today on the MAHA ELEVATE.
I’ll keep you updated at Second Opinion, and any investors, entrepreneurs and operators reading: I’d love your take! I’ll share a more extended analysis on how operators, legal experts and funders are thinking about this new program for any premium subscribers. To read more about another CMS model, the ACCESS program, check out our prior coverage.

Not already a Second Opinion subscriber?
Get weekly insights on health‑tech delivered straight to your inbox. Join the mailing list for free
Or copy & paste this link into your browser:
https://secondopinion.media/subscribe
Upcoming Sessions
Live conversations with the people shaping healthcare.
Verifying AI in Medicine: Is Healthcare AI Actually Ready for Deployment?
Is AI ready for real-world clinical care? Dr. Zak Kohane and Protege’s Engy Ziedan debate what it takes to safely trust AI in diagnosis and treatment, from benchmark performance and clinical evidence to whether we’re holding AI to a higher standard than humans.
Why Are Hospitals Hiring Chief AI Officers?
As AI moves from pilots into day-to-day healthcare operations, health systems are having to decide who should actually own the
Where are AI Agents Actually Working in Healthcare, and Why?
While the healthcare industry remains locked in a high-level debate over the theoretical potential of artificial intelligence, a select group of
Top Employers Share What Healthcare Startups Need to Know in 2026
As enterprise health purchasers face volatile medical cost trends and tightening operational margins, the standard vendor pitch of "improved clinical efficiency&
Peptide Therapy: Where Do We Go From Here?
Watch the full webinar Peptide therapies have moved from niche biohacking circles into mainstream medicine, reshaping conversations around weight management, metabolic health,
Not everyone can access the top 1% of physicians. Will AI change that?
Historically, top-tier medical expertise was limited by wealth and geography. As AI reshapes healthcare delivery, a vital question emerges: can it democratize intelligence to give everyone access to the caliber of care typically reserved for the top 1%?
Privacy AI and the Future of HIPAA
Watch the Full Webinar As AI reshapes healthcare and more patient data flows beyond traditional clinical settings, the rules governing privacy, access,
What will AI do for employer healthcare and benefits?
Employer healthcare may be one of the most practical — and overlooked — proving grounds for AI.
Hospitals as the new go-to-market, lessons from the trenches
Watch the Full Webinar Health systems are entering a new frontier, one where innovation isn’t optional, and meaningful change requires creativity,